tiprankstipranks
Advertisement
Advertisement
Humacyte announces V012 study of ATEV meets primary endpoint
PremiumThe FlyHumacyte announces V012 study of ATEV meets primary endpoint
5d ago
Humacyte announces common stock offering, no amount given
Premium
The Fly
Humacyte announces common stock offering, no amount given
5d ago
Humacyte Shareholders Approve Governance Changes and Share Increase
Premium
Company Announcements
Humacyte Shareholders Approve Governance Changes and Share Increase
6d ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
26d ago
Humacyte reports Symvess under contract with Strategic Acquisition Center of VA
Premium
The Fly
Humacyte reports Symvess under contract with Strategic Acquisition Center of VA
27d ago
Humacyte price target raised to $1.50 from $1 at TD Cowen
Premium
The Fly
Humacyte price target raised to $1.50 from $1 at TD Cowen
1M ago
Humacyte Receives Nasdaq Notice on Minimum Bid Requirement
PremiumCompany AnnouncementsHumacyte Receives Nasdaq Notice on Minimum Bid Requirement
1M ago
Humacyte (HUMA) Motion to Dismiss Ruling Keeps Key Securities Claims Alive 
Premium
Class Action
Humacyte (HUMA) Motion to Dismiss Ruling Keeps Key Securities Claims Alive 
1M ago
Analyst Reiterates Buy on Humacyte, Citing Hemodialysis Upside and KOL Support, Keeps $1 Price Target Unchanged
Premium
Ratings
Analyst Reiterates Buy on Humacyte, Citing Hemodialysis Upside and KOL Support, Keeps $1 Price Target Unchanged
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100